Page last updated: 2024-08-24

pivalyloxymethyl butyrate and Leukemia-Lymphoma, Adult T-Cell

pivalyloxymethyl butyrate has been researched along with Leukemia-Lymphoma, Adult T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batova, A; Diccianni, MB; Nudelman, A; Rephaeli, A; Shao, LE; Tanaka, T; Yu, AL; Yu, J	1

Other Studies

1 other study(ies) available for pivalyloxymethyl butyrate and Leukemia-Lymphoma, Adult T-Cell

Article	Year
The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines. Blood, 2002, Nov-01, Volume: 100, Issue:9 Topics: Acetylation; Acute Disease; Apoptosis; Butyrates; Cell Division; Child; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Genes, MDR; Hematopoietic Stem Cells; Histone Deacetylase Inhibitors; Histones; HL-60 Cells; Humans; Infant; Inhibitory Concentration 50; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Neoplasm Proteins; Neoplasms; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Processing, Post-Translational; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay	2002

Article

Year

The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.

Blood, 2002, Nov-01, Volume: 100, Issue:9

Topics: Acetylation; Acute Disease; Apoptosis; Butyrates; Cell Division; Child; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Genes, MDR; Hematopoietic Stem Cells; Histone Deacetylase Inhibitors; Histones; HL-60 Cells; Humans; Infant; Inhibitory Concentration 50; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Neoplasm Proteins; Neoplasms; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Processing, Post-Translational; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay

2002